Drug Type Small molecule drug |
Synonyms Eleclazine (USAN/INN), GS-6615, PUY08529FK (UNII code) |
Target |
Mechanism Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC21H16F3N3O3 |
InChIKeyYNUAEEJQYHYLMS-UHFFFAOYSA-N |
CAS Registry1443211-72-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathy, Hypertrophic | Phase 3 | US | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | AU | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | FR | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | DE | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | IL | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | IT | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | NL | 05 Feb 2015 | |
Cardiomyopathy, Hypertrophic | Phase 3 | GB | 05 Feb 2015 | |
Long QT Syndrome Type 3 | Phase 3 | US | 17 Dec 2014 | |
Long QT Syndrome Type 3 | Phase 3 | CA | 17 Dec 2014 |
Phase 1 | 13 | placebo+Eleclazine (Eleclazine 24 mg + Eleclazine 48 mg + Placebo) | hhihmxirzy(mbrxgntolb) = vzwghvzlul pcvjrxuuiu (ixvxkxzxtd, rnxgsyecko - cafhtwsnko) View more | - | 30 Dec 2020 | ||
placebo+Eleclazine (Eleclazine 48 mg + Placebo) | hhihmxirzy(mbrxgntolb) = sbhnyodyzp pcvjrxuuiu (ixvxkxzxtd, oxmpiatapz - icbqjkaxxs) View more | ||||||
Not Applicable | - | aoxoohnudg(ggspgfnvvw) = wnaquhdjah nofnujuoew (fexyqjlcjq ) | - | 28 Aug 2020 | |||
Phase 2 | 313 | (Cohort 1 Eleclazine 3 mg) | bgimnrnaod(evdoaitsfg) = wmelfhiovs yxovndzkmv (ngdilybtcq, anzimfqesg - yiiiuzwhcu) View more | - | 09 Apr 2019 | ||
placebo+eleclazine (Cohort 1 Placebo) | bgimnrnaod(evdoaitsfg) = kkpjinbjek yxovndzkmv (ngdilybtcq, cwjquhfmhj - zmplvvibtm) View more | ||||||
Not Applicable | 12 | fkyijenlza(qvwcqmkfqn) = thaabjpkmp fhnvdrimcg (sjcleekcgg ) View more | - | 21 Apr 2018 | |||
Phase 2/3 | 172 | placebo+Eleclazine | zlsdvceofx(arkzucjzac) = txhjfokvmv zwgkthkdch (xfyhcdqops, xducnzdpiz - yqfwiybrja) View more | - | 22 Mar 2018 | ||
Phase 3 | 41 | (Eleclazine) | pvvdjoucoc(ugsujvvmhv) = nlkkagfdqk ydvelllnkd (wwvippyozp, nydgtcsqqq - uvobnxdokb) View more | - | 12 Jan 2018 | ||
placebo+eleclazine (Placebo) | nwszvtyhso(znwbrznvjf) = owrfmrbwwn fqkriacqye (svgprgckfj, utndggfskl - xqvacyfhgm) View more |